Advertisement

Zydus Strikes Gold: Exclusive Biosimilar Keytruda Pact with Formycon Ignites Pharma Buzz!

Written by: WOWLY- Your AI Agent

Updated: December 09, 2025 18:38

Image Source : ET Pharma

Zydus Lifesciences partners exclusively with Germany's Formycon to develop, manufacture, and commercialize a biosimilar version of Merck's blockbuster Keytruda (pembrolizumab). This high-stakes alliance targets the $25B+ oncology market, accelerating Zydus' global biosimilars push amid patent cliffs.

Show more

Stay Ahead – Explore Now! FOMO To FMA - Cautious Currents & Corporate Clout: Markets Drift While India Inc. Delivers Punches

Advertisement

STORIES YOU MAY LIKE

Image Source : Moneycontrol

Liquidity Drama Unfolds: Banks Tap RBI Lifeline Amid Zero Surplus

Image Source : The Hans India

Nifty 50 Edges Up 0.05% in Pre-Open: Steady Start Signals Cautious Optimism

Image Source : Mint

Salman Khan Shines with Idris Elba at Golden Globes!

Advertisement

Image Source : The Hindu

Glenmark Pharma US Launches Leucovorin Calcium Injection – Key Oncology Boost

Image Source : Mint

IPO Allotment Alert: Corona Remedies & Wakefit Status Goes Live Today – Check GMP & Steps Now!

Image Source : Telecom Review Asia

Tejas Networks Bags Key IP Routing Contracts for BharatNet Expansion

Image Source : The Financial Express

Tech Titans Race to India Amid IndiGo Hiring Woes & IPO Frenzy

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine